Clinical Trial Details

EORTC-1707-GITCG

Back to Clinical Trials Database

Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (N+ and/or R1): an open label randomized controlled phase-2-study (VESTIGE)

Study documentation

Trial Status Closed to Patient Entry
Dates Date of activation: 17-Jul-2019
Date Step1 close: 06-Jun-2022
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 240 - All Groups: 240
Treatment Drug
Fluorouracil, Ipilimumab, Capecitabine, Cisplatin, Docetaxel, Epirubicin, Leucovorin, Oxaliplatin, Nivolumab
Study Staff Florian Lordick (Study Coordinator) , Universitaetsklinikum Leipzig UCCL-Krebszentrum, Leipzig
Jose Casas (TR Scientist) , EORTC Headquarters, Brussels
Ilse Coppens (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Shani De Coster (Data Manager) , EORTC Headquarters, Brussels
Nathalie Elaut (Data Manager) , EORTC Headquarters, Brussels
Irina Ghislain (QoL Specialist) , EORTC Headquarters, Brussels
Anne Giraut (Clinical Scientist) , EORTC Headquarters, Brussels
Liliane Henkes (Lead CRA) , EORTC Headquarters, Brussels
Ana Joaquim (Clinical Research Physician) , EORTC Headquarters, Brussels
Maren Kristina Knoedler (Study Co-Coordinator) , Universitaetsklinikum Leipzig UCCL-Krebszentrum, Leipzig
Belma Malanda (Project Manager) , EORTC Headquarters, Brussels
Murielle Mauer (Statistician) , EORTC Headquarters, Brussels
Sara Meloen (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Anja Mestnik (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Jerome Rapion (Statistical Analyst) , EORTC Headquarters, Brussels
Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Maira Seini (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Jose Silva (Clinical Research Physician) , EORTC Headquarters, Brussels
Elizabeth Smyth (Study Co-Coordinator) , University of Oxford -Oncology, Oxford
Lien Styns (Data Manager) , EORTC Headquarters, Brussels
Katheline Vander Heggen (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Sofie Verschueren (Clinical Operations Manager) , EORTC Headquarters, Brussels
Type of cancer Gastric
Participating groups EORTC Gastrointestinal Tract Cancer Group
Recruiting centers Azienda Ospedaliera Papa Giovanni XXIII (Bergamo, Italy)
CHRU de Lille - Hopital Huriez (Lille, France)
Cambridge University Hospital NHS - Addenbrookes Hospital (Cambridge, United Kingdom)
Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin (Berlin, Germany)
Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (Berlin, Germany)
Complejo Hospitalario de Navarra (Pamplona, Spain)
Gustave Roussy (VILLEJUIF CEDEX, France)
Hopital Prive Jean Mermoz (LYON CEDEX 08, France)
Hospital Clinico Universitario De Valencia (Valencia, Spain)
Hospital Universitario 12 De Octubre (Madrid, Spain)
ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain)
IRCCS - Fondazione G. Pascale (Napoli, Italy)
Istituto Europeo di Oncologia (Milano, Italy)
Kliniken Essen-Mitte (Essen, Germany)
Klinikum Rechts der isar Der Technische Universitaet Muenchen - Klinikum Rechts Der Isar (Muenchen, Germany)
Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland)
Masaryk Memorial Cancer Institute (Brno, Czech Republic)
Oslo University Hospital - Ullevaal Hospital (Oslo, Norway)
Rabin Medical Center - Tel Aviv (Petah Tikva, Israel)
Rambam Health Care Campus, Oncology Institute (Haifa, Israel)
Royal Marsden Hospital - Chelsea, London (London, United Kingdom)
Royal Marsden Hospital - Sutton, Surrey (Surrey, United Kingdom)
SLK-Kliniken Heilbronn (Heilbronn, Germany)
Universitaetsklinikum Hamburg-Eppendorf KE - University Cancer Center (Hamburg, Germany)
Universitaetsklinikum Leipzig UCCL-Krebszentrum (Leipzig, Germany)
University College Hospital (London, United Kingdom)
Protocol summary http://clinicaltrials.gov/study/NCT03443856
NCT number NCT03443856
EudraCT 2018-000406-36
Financial Support Educational Grant